At the same time, a significant finding was that co-mutation of ARID1A and TP53 in Chinese children with r/r MB-NHL is associated with insensitivity to chemotherapy and CAR-T cell treatment. The gene discussed is ARID1A; the disease is non-Hodgkin lymphoma.